John J. Boniface - 26 Jul 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
Chief Scientific Officer
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Issuer symbol
SERA
Transactions as of
26 Jul 2022
Net transactions value
-$7,349
Form type
4
Filing time
27 Jul 2022, 18:54:01 UTC
Previous filing
19 Jul 2022
Next filing
09 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SERA Class A Common Stock Sale $5,859 -2,725 -5.5% $2.15 46,510 26 Jul 2022 Direct F1, F2
transaction SERA Class A Common Stock Options Exercise $730 +1,000 +2.2% $0.7300 47,510 27 Jul 2022 Direct
transaction SERA Class A Common Stock Sale $2,220 -1,000 -2.1% $2.22 46,510 27 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Options Exercise $0 -1,000 -54% $0.000000 844 27 Jul 2022 Class A Common Stock 1,000 $0.7300 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.27, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3 The shares subject to this option are fully vested and exercisable.